Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
RFK Jr.’s vaccine advisers plan biggest change yet to childhood schedule - 2What we know about Renee Nicole Good, the woman who was killed by an ICE officer in Minneapolis
- 3The Best Computer games for Multiplayer Fun
- 4How Would You Like to Deal with Your Funds?
- 5Support Your Wellness: 20-Minute Home Exercises That Work
- Best Amusement Park in Asia: Which One Is a Must-Visit
- Vote In favor of Your Favored Video Conferencing Administration
- Bombardier Global 8000 Enters Service
- 10 Demonstrated Tips to Dominate Video Altering on Your Cell phone in 2023
- She was the supermodel dubbed 'The Face' in the '80s. Joining OnlyFans in her 60s taught her a lot.
- This Tiny Neon Frog Dwells in the Clouds
- Elite Execution Wall televisions for Film Darlings
- Katz alleges Army Radio workers misled High Court in bid to halt closure
- Flu cases are spiking earlier than usual. What you need to know.
